Patent 7491507 was granted and assigned to Chr. Hansen on February, 2009 by the United States Patent and Trademark Office.
Use of a lactic acid bacterium comprising a cell wall proteinase of around 200 kDa to prepare peptides with anti-hypertensive properties and a method for obtaining such a lactic acid bacterium.